Theranos Serves as a Cautionary Tale for Biotech Funding Post author:Sam Post published:March 15, 2018 Post category:BioPharma There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace You Might Also Like BioProcess International Conference Brings Biotech Together in Boston September 21, 2017 How Biogen Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months April 16, 2017 Zika Testing Mistakes Require Re-testing Of Over 400 Specimens February 16, 2017
How Biogen Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months April 16, 2017
